CSL shares surge – here’s why
CSL: +8.51%: A strong 1H22 for CSL relative to market expectations today plus their guidance was positive for the full year.
CSL share price falls following acquisition chatter
CSL -2.5%: News overnight that CSL is apparently in talks to buy Swiss-based drug maker Vifor Pharma saw shares lower today.
CSL meets FY21 but guidance disappoints
CSL -1.47%: FY21 Result: A solid FY21 result for CSL booking a ~3% beat at the profit line.
